CLTN.SW

COLTENE Holding AG [CLTN.SW] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

CLTN.SW Stock Summary

CLTN.SW has more than 2 years of cash runway (30 months)

Earnings are expected to fall -100% next year

EPS has been decreasing for the past 3 years (Yearly statements)

EPS has been decreasing for the past 3 quarters (Quarter statements)

Top 10 Correlated ETFs

CLTN.SW

Top 10 Correlated Stocks

CLTN.SW

In the News

CLTN.SW Financial details

Company Rating

Strong Buy

Market Cap

332.24M

Income

37.95M

Revenue

509.85M

Book val./share

16.21

Cash/share

3.07

Dividend

3.3

Dividend %

4.83%

Employees

1.18K

Optionable

Shortable

Yes

Earnings

08 Mar 2024

P/E

15.7

Forward P/E

PEG

3.41

P/S

1.53

P/B

3.64

P/C

16.94

P/FCF

27.02

Quick Ratio

0.33

Current Ratio

1.82

Debt / Equity

0.46

LT Debt / Equity

EPS (TTM)

6.35

EPS next Y

EPS next Q

EPS this Y

-54.02%

EPS next Y

EPS next 5Y

EPS last 5Y

-9.8%

Revenue last 5Y

-2.38%

Revenue Q/Q

-15.32%

EPS Q/Q

-80.95%

SMA20

-5.17%

SMA50

-3.51%

SMA100

-17.91%

Inst Own

Inst Trans

ROA

14%

ROE

24%

ROC

0.3%

Gross Margin

63%

Oper. Margin

13%

Profit Margin

10%

Payout

76%

Shs Outstand

Shs Float

Target Price

52W Range

54.4-80.1

52W High

-35%

52W Low

-3.7%

RSI

Rel Volume

1.19

Avg Volume

4.12K

Volume

4.92K

Perf Week

-6.14%

Perf Month

-7.8%

Perf Quarter

-17.33%

Perf Half Y

-21.21%

Beta

0.941

Volatility

1.67%, 1.83%

Prev Close

-2.26%

Price

Change

-2.26%

CLTN.SW Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	45.83	41.56	46.74	44.71	40.62
Net income per share	3.35	1.38	5.31	4.35	2
Operating cash flow per share	3.98	5.82	5.44	3.92	4.35
Free cash flow per share	1.76	4.24	3.78	2.53	2.89
Cash per share	3.84	6.44	4.31	4.05	3.07
Book value per share	15.27	15.1	17.97	18.78	16.21
Tangible book value per share	14.7	14.21	17.15	17.73	15.15
Share holders equity per share	15.27	15.1	17.97	18.78	16.21
Interest debt per share	10.14	10.23	7.25	7.92	7.67
Market cap	530.56M	513.88M	671.58M	455.26M	427.82M
Enterprise value	567.39M	535.75M	688.77M	478.11M	454.46M
P/E ratio	26.49	62.42	21.18	17.51	35.81
Price to sales ratio	1.94	2.07	2.41	1.7	1.76
POCF ratio	22.31	14.76	20.65	19.44	16.47
PFCF ratio	50.59	20.28	29.7	30.14	24.74
P/B Ratio	5.82	5.69	6.25	4.06	4.42
PTB ratio	5.82	5.69	6.25	4.06	4.42
EV to sales	2.07	2.16	2.47	1.79	1.87
Enterprise value over EBITDA	16.2	13.9	14.33	11.99	17.07
EV to operating cash flow	23.86	15.39	21.18	20.41	17.5
EV to free cash flow	54.1	21.15	30.46	31.66	26.28
Earnings yield	0.04	0.02	0.05	0.06	0.03
Free cash flow yield	0.02	0.05	0.03	0.03	0.04
Debt to equity	0.66	0.67	0.4	0.42	0.46
Debt to assets	0.31	0.32	0.23	0.25	0.25
Net debt to EBITDA	1.05	0.57	0.36	0.57	1
Current ratio	1.48	1.49	1.76	1.82	1.6
Interest coverage	40.98	29.26	105.53	150.48	23.63
Income quality	1.19	4.23	1.03	0.9	2.17
Dividend Yield	0.03	0.02	0.03	0.04	0.05
Payout ratio	0.89	1.09	0.57	0.76	1.65
Sales general and administrative to revenue	0.02	0.02	0.02	0.01	0.09
Research and developement to revenue	0.04	0.04	0.03	0.03	0.04
Intangibles to total assets	0.01	0.02	0.03	0.03	0.04
Capex to operating cash flow	-0.56	-0.27	-0.3	-0.36	-0.33
Capex to revenue	-0.05	-0.04	-0.04	-0.03	-0.04
Capex to depreciation	-2.18	-0.87	-1.54	-1.24	-1.27
Stock based compensation to revenue	0	0	0	0	0
Graham number	33.93	21.64	46.33	42.88	27.01
ROIC	0.15	0.07	0.22	0.17	0.1
Return on tangible assets	0.11	0.04	0.17	0.14	0.07
Graham Net	-1.05	-0.08	1.03	1.34	-0.6
Working capital	45.16M	44.57M	56.57M	60.06M	44.47M
Tangible asset value	88.81M	86.64M	102.49M	105.94M	90.52M
Net current asset value	39.73M	38.18M	51.62M	54.72M	37.47M
Invested capital	0.66	0.67	0.4	0.42	0.46
Average receivables	53.03M	48.64M	41.74M	40.44M	39.94M
Average payables	12.16M	9.79M	9.92M	10.22M	9.73M
Average inventory	56.94M	54.83M	55.57M	61.31M	61M
Days sales outstanding	71.44	64.2	52.02	56.13	58.33
Days payables outstanding	45.36	28.96	43.4	30.71	22.22
Days of inventory on hand	222.53	193.35	213.73	232.27	117.99
Receivables turnover	5.11	5.69	7.02	6.5	6.26
Payables turnover	8.05	12.6	8.41	11.88	16.42
Inventory turnover	1.64	1.89	1.71	1.57	3.09
ROE	0.22	0.09	0.3	0.23	0.12
Capex per share	-2.23	-1.58	-1.66	-1.39	-1.45

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric	2021-12-31	2022-06-30	2022-12-31	2023-06-30	2023-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	22.76	22.58	22.12	22	18.63
Net income per share	2.27	2.03	2.32	1.68	0.32
Operating cash flow per share	3.17	1.89	2.03	3.44	0.9
Free cash flow per share	2.28	1.3	1.22	2.79	0.1
Cash per share	4.36	4.24	4.06	3.92	3.07
Book value per share	18	17.24	18.78	16.87	16.21
Tangible book value per share	17.18	16.34	17.73	15.86	15.15
Share holders equity per share	18	17.24	18.78	16.87	16.21
Interest debt per share	7.48	9.34	8.02	8.56	7.92
Market cap	670.65M	491.78M	455.3M	423.06M	427.85M
Enterprise value	687.84M	521.13M	478.14M	449.62M	454.49M
P/E ratio	12.4	10.14	8.2	10.55	55.56
Price to sales ratio	4.94	3.64	3.44	3.22	3.84
POCF ratio	35.48	43.49	37.58	20.56	79.29
PFCF ratio	49.28	63.15	62.24	25.33	723.93
P/B Ratio	6.24	4.77	4.06	4.2	4.42
PTB ratio	6.24	4.77	4.06	4.2	4.42
EV to sales	5.07	3.86	3.62	3.42	4.08
Enterprise value over EBITDA	32.43	26.11	22.07	25.16	52.95
EV to operating cash flow	36.39	46.09	39.47	21.85	84.23
EV to free cash flow	50.55	66.91	65.36	26.92	769.01
Earnings yield	0.02	0.02	0.03	0.02	0
Free cash flow yield	0.02	0.02	0.02	0.04	0
Debt to equity	0.4	0.53	0.42	0.5	0.46
Debt to assets	0.23	0.28	0.25	0.27	0.25
Net debt to EBITDA	0.81	1.47	1.05	1.49	3.1
Current ratio	1.76	1.59	1.82	1.59	1.6
Interest coverage	10.52	14.74	21.58	12.39	2.23
Income quality	1.4	0.93	0.87	2.05	2.8
Dividend Yield	0	0.04	0	0.05	0
Payout ratio	0	1.63	0	1.97	0
Sales general and administrative to revenue	0.11	0	0.09	0	0
Research and developement to revenue	0.07	0	0.07	0	0
Intangibles to total assets	0.03	0.03	0.03	0.03	0.04
Capex to operating cash flow	-0.28	-0.31	-0.4	-0.19	-0.89
Capex to revenue	-0.04	-0.03	-0.04	-0.03	-0.04
Capex to depreciation	-1.57	-1.07	-1.4	-1.13	-1.41
Stock based compensation to revenue	0	0	0	0	0
Graham number	30.29	28.06	31.32	25.23	10.84
ROIC	0.1	0.08	0.09	0.07	0.02
Return on tangible assets	0.07	0.06	0.08	0.06	0.01
Graham Net	0.72	-0.41	1.35	-0.13	-0.6
Working capital	56.57M	51.3M	60.06M	48.2M	44.47M
Tangible asset value	102.49M	97.65M	105.94M	94.75M	90.52M
Net current asset value	51.62M	46.96M	54.72M	43.22M	37.47M
Invested capital	0.4	0.53	0.42	0.5	0.46
Average receivables	0	0	0	0	0
Average payables	0	0	0	0	0
Average inventory	0	0	0	0	0
Days sales outstanding	24.51	25.83	27.97	28.27	31.37
Days payables outstanding	11.5	11.36	8.05	8.87	11.49
Days of inventory on hand	56.61	65.41	60.89	58.54	61.01
Receivables turnover	3.67	3.48	3.22	3.18	2.87
Payables turnover	7.83	7.92	11.18	10.15	7.83
Inventory turnover	1.59	1.38	1.48	1.54	1.48
ROE	0.13	0.12	0.12	0.1	0.02
Capex per share	-0.89	-0.59	-0.8	-0.65	-0.8

CLTN.SW Dividend History

CLTN.SW Frequently Asked Questions

What is COLTENE Holding AG stock symbol ?

COLTENE Holding AG is a CH stock and trading under the symbol CLTN.SW

What is COLTENE Holding AG stock quote today ?

COLTENE Holding AG stock price is $52 today.

Is COLTENE Holding AG stock public?

Yes, COLTENE Holding AG is a publicly traded company.

Something similar

Top by Market Cap

Top Correlated ETFs

Top Correlated Stocks

Similar Market Cap

Company Profile

Volume Average 4.12K
Market Capitalization 332.24M
Employee 1.18K
CEO Mr. Dominik Arnold
Headquarters Altstätten,CH
IPO Date 2006-06-23
Website https://www.coltene.com

COLTENE Holding AG develops, manufactures, and sells disposables, tools, and equipment for dentists and dental laboratories in Europe, the Middle East, Africa, North America, Latin America, and Asia/Oceania. It offers restoration products, including conventional composites, bulk-fill composites, CAD/CAM solutions, core build-ups, bondings, etching gels, temporary materials, luting, curing lights, and characterizations; and endodontics products, such as posts, rotary and hand files, irrigation solutions, obturation and sealing materials, Gutta-percha and paper points, endo engines, apex locators, and endo accessories. The company also provides prosthetics comprising bite registration, retractions, A-silicones, C-silicones, and accessories; and treatment auxiliaries consisting of dental rolls and dispensers, cotton pellets and dispensers, aspirator tips, dental dams and dam kits, dental dam clamps and accessories, dental scalers, electrosurgery, and occlusion verification products. In addition, it offers infection control products, which include ultrasonic cleaning units, patient bibs, headrest covers, and sterile covers; rotary instruments, such as diamond and carbide burs, polishers, kits, and accessories; and laboratory products comprising gingiva masks, lab putty products, model making products, waxes, occlusion control products, accessories, HP burs, and silicone polishers. The company was formerly known as Medisize Holding AG and changed its name to COLTENE Holding AG in April 2008. COLTENE Holding AG was incorporated in 2005 and is headquartered in Altstätten, Switzerland.